A comparative analysis of postprocedural troponin levels and the impact of renal impairment in patients undergoing pulmonary vein isolation: pulsed field ablation vs. radiofrequency ablation
- PMID: 40753251
- PMCID: PMC12317538
- DOI: 10.1186/s40001-025-02964-y
A comparative analysis of postprocedural troponin levels and the impact of renal impairment in patients undergoing pulmonary vein isolation: pulsed field ablation vs. radiofrequency ablation
Abstract
Background: Pulsed field ablation (PFA) has emerged as a novel nonthermal modality for pulmonary vein isolation (PVI) in atrial fibrillation (AF). While it offers distinct advantages over traditional radiofrequency ablation (RFA), including a favorable safety profile, its impact on myocardial injury, as reflected by biomarker plasma concentrations, remains underexplored.
Objectives: This study aimed to compare postprocedural high-sensitivity troponin-T (hs-TnT) and creatine kinase (CK) levels in patients undergoing PVI with PFA versus RFA and to identify independent predictors of myocardial injury.
Methods: We analyzed 94 patients (48 PFA, 46 RFA) undergoing PVI for paroxysmal or persistent AF. Biomarkers (hs-TnT and CK) were measured preprocedure and 24 h postprocedure. Baseline clinical and procedural characteristics were evaluated for comparability. Statistical analyses included linear regression with permutation feature importance to identify predictors of postprocedural troponin levels.
Results: Patients undergoing PFA exhibited significantly higher median hs-TnT levels at 24 h postprocedure compared to those treated with RFA (1071.0 ng/L [IQR: 861.0-1316.5] vs. 602.5 ng/L [IQR: 504.0-795.5]; p < 0.001). Similarly, CK levels were markedly higher in the PFA group (286.0 U/L [IQR: 215.0-356.5] vs. 122.5 U/L [IQR: 90.5-190.5]; p < 0.001). Baseline levels of both biomarkers were comparable between groups. Linear regression identified PFA as the most significant determinant of troponin plasma concentration, followed by preprocedural GFR, with reduced GFR correlating with greater troponin elevation.
Conclusions: PFA is associated with higher myocardial biomarker plasma concentration compared to RFA, suggesting greater myocardial injury. Reduced GFR amplifies this effect, underscoring the importance of careful patient selection and procedural planning, particularly in patients with renal impairment. While PFA shows promise as a safe and effective ablation strategy, further research is needed to assess its long-term clinical implications.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The implementation of this study was approved by a positive ethics vote from the Ethics Committee of the University of Rostock (Reg.-Nr. A2023-0213). All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Informed consent was obtained from all individual participants included in the study. Competing interests: The authors declare no competing interests.
Figures



References
-
- Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–21. 10.1177/1747493019897870. - PubMed
-
- Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G, EAST-AFNET 4 Trial Investigators. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305–16. 10.1056/NEJMoa2019422. - PubMed
-
- Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66. 10.1056/NEJM199809033391003. - PubMed
-
- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, ESC Scientific Document Group. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the european society of cardiology (ESC) Developed with the special contribution of the european heart rhythm association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. 10.1093/eurheartj/ehaa612. - PubMed
-
- Ouyang F, Bänsch D, Ernst S, Schaumann A, Hachiya H, Chen M, Chun J, Falk P, Khanedani A, Antz M, Kuck KH. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation. 2004;110(15):2090–6. 10.1161/01.CIR.0000144459.37455.EE. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous